Neurogenic Cells

Neurogenic (neural-lineage) cells are directed toward neuronal and glial phenotypes and are studied in neurodegenerative and neurodevelopmental contexts.

At Stem Plus, Neurogenic Cells are prepared in a GMP-certified laboratory and released from a certified cell bank — characterised, sterile and reproducible for every patient.

How Neurogenic Cells are used

The therapeutic value of Neurogenic Cells lies less in cells "becoming" new tissue and more in their paracrine signalling — the growth factors and vesicles they release to calm inflammation and recruit the body's own repair. Delivery is matched to the target: intravenous for systemic conditions, or localised where appropriate.

Conditions where Neurogenic Cells feature

Autism Spectrum Disorder Multiple Sclerosis Parkinson's Disease Cerebral Palsy Spinal Muscular Atrophy Developmental Cognitive Delay Peripheral Neuropathy Stroke Recovery

Quality & safety

GMP-certified preparation in the European Union
Characterised, viability-tested cells from a certified bank
Personalised dosing within a physician-led protocol
Transparent pricing — €3,000–€8,000 per programme

Educational information. Neurogenic Cells protocols for several conditions remain investigational; outcomes vary by patient.

How Neurogenic Cells are used

Conditions where Neurogenic Cells feature

Quality & safety

Explore

Terapia celular de nivel europeo, sin precios europeos.